Inovio Pharmaceuticals specializes in DNA-based immunotherapies for HPV-related conditions, cancer, and infectious diseases. The company's flagship drug, INO-3107, shows promise for treating recurrent ...
WHITE RIVER JUNCTION, Vt., Nov. 18, 2025 /PRNewswire/ -- QUEL Imaging, a leader in biomedical optical characterization tools and services, and the Institut National d'Optique (INO), Canada's premier ...
Stephens initiated coverage on INOVIO Pharmaceuticals Inc (NASDAQ:INO), noting the company’s diversified clinical pipeline of therapeutic and vaccine candidates, which the company is looking to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results